Dose escalation for non-small cell lung cancer: analysis and modelling of published literature.

Dose escalation for non-small cell lung cancer: analysis and modelling of published literature.

PURPOSE: To review the published clinical data on non-small cell lung cancer treated with radical radiotherapy to confirm a dose-response relationship as a basis for further dose-escalation trials. METHODS: Twenty-four published clinical trials were identified, 16 of which - with 29 different standa...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Partridge, M, Ramos, M, Sardaro, A, Brada, M
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2011

Gelijkaardige items

Radiation dose escalation in stage III non-small-cell lung cancer.
door: William Thomas Sause, et al.
Gepubliceerd in: (2011-11-01)

Review of hypofractionated small volume radiotherapy for early-stage non-small cell lung cancer.
door: Brock, J, et al.
Gepubliceerd in: (2008)

Influence of dose calculation algorithms on isotoxic dose-escalation of non-small cell lung cancer radiotherapy.
door: Panettieri, V, et al.
Gepubliceerd in: (2010)

Dyspnea in Patients Receiving Radical Radiotherapy for Non-Small Cell Lung Cancer: A Prospective Study
door: Angela Sardaro, et al.
Gepubliceerd in: (2020-12-01)

A planning study of proton therapy dose escalation for non-small cell lung cancer
door: Arno C. Hessels, et al.
Gepubliceerd in: (2024-07-01)

Improvement in tumour control probability with active breathing control and dose escalation: a modelling study.
door: Partridge, M, et al.
Gepubliceerd in: (2009)

A current review of dose-escalated radiotherapy in locally advanced non-small cell lung cancer
door: Ma Li, et al.
Gepubliceerd in: (2019-03-01)

Investigating the potential of proton therapy for hypoxia-targeted dose escalation in non-small cell lung cancer
door: Andreas Köthe, et al.
Gepubliceerd in: (2021-10-01)

Optimizing collimator margins for isotoxically dose-escalated conformal radiation therapy of non-small cell lung cancer.
door: Warren, S, et al.
Gepubliceerd in: (2014)

Strategies of dose escalation in the treatment of locally advanced non-small cell lung cancer: image guidance and beyond
door: Alexander eChi, et al.
Gepubliceerd in: (2014-06-01)

Optimising stereotactic body radiotherapy for non-small cell lung cancer with volumetric intensity-modulated arc therapy--a planning study.
door: Brock, J, et al.
Gepubliceerd in: (2012)

Effective avoidance of a functional spect-perfused lung using intensity modulated radiotherapy (IMRT) for non-small cell lung cancer (NSCLC): an update of a planning study.
door: Lavrenkov, K, et al.
Gepubliceerd in: (2009)

Prospectively scored pulmonary toxicities in non-small cell lung cancer: Results from a randomized phase II dose escalation trial
door: Christina M. Lutz, et al.
Gepubliceerd in: (2021-03-01)

Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: opportunities for treatment improvement.
door: Fenwick, J, et al.
Gepubliceerd in: (2009)

Personalized dose escalation in anal cancer
door: Robinson, M, et al.
Gepubliceerd in: (2016)

Radiobiological determination of dose escalation and normal tissue toxicity in definitive chemoradiation therapy for esophageal cancer.
door: Warren, S, et al.
Gepubliceerd in: (2014)

Internal dose escalation is associated with increased local control for non-small cell lung cancer (NSCLC) brain metastases treated with stereotactic radiosurgery (SRS)
door: Christopher Abraham, MD, et al.
Gepubliceerd in: (2018-04-01)

UK proposal for three parallel dose escalation studies in radiotherapy (RT) for Stage I-III non-small cell lung cancer (NSCLQC)-DEAL-RT
door: Hughes, S, et al.
Gepubliceerd in: (2007)

Complement factor H targeting antibody GT103 in refractory non-small cell lung cancer: a phase 1b dose escalation trial
door: Jeffrey M. Clarke, et al.
Gepubliceerd in: (2025-01-01)

The role of biological dose-escalation for pancreatic cancer
door: Anna M.E. Bruynzeel, et al.
Gepubliceerd in: (2019-09-01)

A phase I/II trial of concurrent chemo-radiation with dose-escalated radiotherapy in patients with stage II or stage III non-small cell lung cancer
door: Landau, D, et al.
Gepubliceerd in: (2013)

Correction: Immune Responses to the Cancer Testis Antigen XAGE-1b in Non Small Cell Lung Cancer Caucasian Patients.
door: Alessandro Sardaro, et al.
Gepubliceerd in: (2016-01-01)

Cardiac-sparing radiotherapy for locally advanced non-small cell lung cancer
door: Louise Turtle, et al.
Gepubliceerd in: (2021-06-01)

FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer
door: Sébastien Thureau, et al.
Gepubliceerd in: (2018-10-01)

The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: a radiobiological investigation
door: Warren, S, et al.
Gepubliceerd in: (2015)

Treatment planning of dose escalation for anal cancer in the PLATO trial
door: Abbott, N, et al.
Gepubliceerd in: (2017)

Normal tissue doses during isotoxically dose escalated lung radiation therapy using MR-linacs
door: Bendall, L, et al.
Gepubliceerd in: (2018)

Phase I Study of Etoposide and Cisplatin Chemotherapy Dose Escalation  with Concurrent Twice-daily Radiotherapy for Patients  with Limited-stage Small Cell Lung Cancer
door: Jing YOU, et al.
Gepubliceerd in: (2017-01-01)

Isotoxic dose escalation with real-time imaging on an MR-linac in lung radiation therapy
door: Bendall, L, et al.
Gepubliceerd in: (2018)

The in-silico feasibility of dose escalated, hypofractionated radiotherapy for rectal cancer
door: Lynsey Devlin, et al.
Gepubliceerd in: (2022-09-01)

Dose escalation of a curcuminoid formulation
door: Crowell James, et al.
Gepubliceerd in: (2006-03-01)

Combining advanced radiotherapy technologies to maximize safety and tumor control probability in stage III non-small cell lung cancer.
door: Guckenberger, M, et al.
Gepubliceerd in: (2012)

RESECTION OF TRACHEAL BIFURCATION IN TREATMENT OF NON-SMALL CELL LUNG CANCER (LITERATURE REVIEW)
door: I. A. Dadyev, et al.
Gepubliceerd in: (2018-11-01)

The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: A radiobiological investigation
door: Carrington, R, et al.
Gepubliceerd in: (2015)

Phase I dose escalation study of vinorelbine and topotecan combination chemotherapy in patients with recurrent lung cancer
door: Kraft Andrew S, et al.
Gepubliceerd in: (2007-12-01)

Moderately Escalated Hypofractionated (Chemo)Radiotherapy Delivered with Helical Intensity-Modulated Technique in Stage III Unresectable Non-Small Cell Lung Cancer
door: Vittorio eDonato, et al.
Gepubliceerd in: (2013-11-01)

Improved Outcomes With Dose Escalated Hypofractionated Radiotherapy for Prostate Cancer
door: Mackenzie, J, et al.
Gepubliceerd in: (2011)

Dose escalation with stereotactic body radiotherapy for cervical cancer treatment
door: Menekse Turna, et al.
Gepubliceerd in: (2024-10-01)

Prospective evaluation of probabilistic dose-escalated IMRT in prostate cancer
door: Wegener Daniel, et al.
Gepubliceerd in: (2020-12-01)

Frontline gefitinib in advanced non-small cell lung cancer: Meta-analysis of published randomized trials
door: Ibrahim Ezzeldin
Gepubliceerd in: (2010-01-01)